Practice
Euglycemic diabetic ketoacidosis associated with the use of a sodium–glucose cotransporter-2 inhibitor
Lydia Zhang and Michael Tamilia
CMAJ June 25, 2018 190 (25) E766-E768; DOI: https://doi.org/10.1503/cmaj.171319
Lydia Zhang
Department of Internal Medicine (Zhang), Sir Mortimer B. Davis Jewish General Hospital; Department of Endocrinology and Metabolism (Tamilia), Jewish General Hospital, Montréal, Que.
MDMichael Tamilia
Department of Internal Medicine (Zhang), Sir Mortimer B. Davis Jewish General Hospital; Department of Endocrinology and Metabolism (Tamilia), Jewish General Hospital, Montréal, Que.
MDArticle Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Respond to this article
Euglycemic diabetic ketoacidosis associated with the use of a sodium–glucose cotransporter-2 inhibitor
Lydia Zhang, Michael Tamilia
CMAJ Jun 2018, 190 (25) E766-E768; DOI: 10.1503/cmaj.171319
Jump to section
Related Articles
Cited By...
- No citing articles found.